Skip to main content

Table 2 Proportions of preventable medication harm by medication class

From: Preventable medication harm across health care settings: a systematic review and meta-analysis

Drug class

ATC code

N studies

Prevalence, %

95% CI

Ï„2

I2 (%)

Analgesics

N02Â¥

4

7

0.5, 19

0.0229

84.00

Antibiotics and antibacterial

J01Â¥

12

12

7, 18

0.0165

87.80

Antithrombotic agents/anticoagulants

B01Â¥

10

11

7, 15

0.0073

78.60

Antidepressants

N06Aβ

4

6

0.4, 17

0.0253

94.90

Antidiabetic

A10Â¥

4

7

0.8, 17

0.0162

77.50

Antiepileptics

N03Â¥

3

4

0.2, 10

0.0029

26.40

Anti-inflammatory and antirheumatic

M01Â¥

5

15

7, 26

0.0166

79.40

Antipsychotics

N05Aβ

4

11

0.2, 32

0.0622

95.60

Cardiovascular

C*

14

16

11, 23

0.0205

90.80

Corticosteroids

H02Â¥

5

2

0.2, 6

0.0066

77.10

Diuretics

C03Â¥

5

6

0.2, 17

0.0365

95.80

Functional gastrointestinal disorders

A03Â¥

3

4

0, 14

0.0183

75.80

Musculoskeletal system

M*

3

9

2.4, 20

0.0142

85.00

Nervous system

N*

6

21

6, 43

0.0784

97.00

Opioids

N02Aβ

5

6

2, 10

0.0045

74.70

Respiratory system-related drugs

R*

4

1

0, 4

0.0061

74.90

Sedatives

N05Cβ

5

16

11, 21

0.0016

33.50

  1. *ATC 1st level—related to mostly body function;
  2. ¥ATC 2nd level—pharmacological or therapeutic subgroup
  3. βATC 3rd and 4th levels—chemical, pharmacological or therapeutic subgroup